FGFC1 Exhibits Anti-Cancer Activity via Inhibiting NF-&#954;B Signaling Pathway in <i>EGFR</i>-Mutant NSCLC Cells.

Feng, Jingwen; Li, Songlin; Zhang, Bing; Duan, Namin; Zhou, Rui; Yan, Shike; Elango, Jeevithan; Liu, Ning; Wu, Wenhui

FGFC1 Exhibits Anti-Cancer Activity via Inhibiting NF-κB Signaling Pathway in EGFR-Mutant NSCLC Cells.

Feng, Jingwen; Li, Songlin; Zhang, Bing; Duan, Namin; Zhou, Rui; Yan, Shike; Elango, Jeevithan; Liu, Ning; Wu, Wenhui.

Afiliación

Feng J; Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Li S; Research Centre of the Ministry of Agriculture and Rural Affairs on Environmental Ecology and Fish Nutrition, Shanghai Ocean University, Shanghai 201306, China.
Zhang B; Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Duan N; Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Zhou R; Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Yan S; Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Elango J; Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Liu N; Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Wu W; Engineering Research Center of Aquatic Product Processing & Preservation, Shanghai Ocean University, Shanghai 201306, China.

Mar Drugs ; 20(1)2022 Jan 17.

Article en En | MEDLINE | ID: mdl-35049931

Asunto(s)

Antineoplásicos/farmacología; Línea Celular Tumoral/efectos de los fármacos; Stachybotrys; Animales; Antineoplásicos/química; Organismos Acuáticos; Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico; Carcinoma de Pulmón de Células no Pequeñas/patología; Puntos de Control del Ciclo Celular/efectos de los fármacos; Receptores ErbB/genética; Humanos; FN-kappa B/metabolismo; Transducción de Señal/efectos de los fármacos

Palabras clave

EGFR-mutant; FGFC1; NF-κB pathway; NSCLC; apoptosis; cell cycle arrest

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Stachybotrys / Línea Celular Tumoral / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Mar Drugs Asunto de la revista: BIOLOGIA / FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google